African Export-Import Bank (Afreximbank) and the Africa Centers for Diseases Control and Prevention (Africa CDC) have announced a plan to collaborate on a $2 billion health security investment plan. This announcement was made at the Global Forum for Vaccine Sovereignty and Innovation in Paris, France. According to the parties, the partnership is expected to bolster health security and economic development across the African continent Related Stories Afreximbank launches $300 million program for climate finance in Africa FG seals $3.
5 billion deal with Afreximbank for textile industry, CNG Vehicles, others Afreximbank has pledged a $ 2 billion facility to the “Africa Health Security Investment Plan,” aimed at supporting the continent’s ambition to enhance health product manufacturing. This initiative will focus on two critical mechanisms: the African Pooled Procurement Mechanism (APPM) and the Platform for Harmonized African Health Products Manufacturing (PHAHM). This collaboration is pivotal in addressing Africa’s health investment challenges, promoting economic development, and strengthening health security.
It also aims to complement GAVI’s innovative financing mechanism, the African Vaccine Manufacturing Accelerator (AVMA), which is set to provide up to $2 billion in financing to African manufacturers of health and pharmaceutical products over the next decade. African pharmaceutical companies face significant challenges, including global health, security, and eco.
